Standard Biotools (LAB) Consolidated Net Income (2016 - 2025)
Historic Consolidated Net Income for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to -$3.0 million.
- Standard Biotools' Consolidated Net Income rose 4016.74% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$119.9 million, marking a year-over-year decrease of 5497.26%. This contributed to the annual value of -$138.9 million for FY2024, which is 8573.97% down from last year.
- Standard Biotools' Consolidated Net Income amounted to -$3.0 million in Q3 2025, which was up 4016.74% from -$15.8 million recorded in Q2 2025.
- Standard Biotools' Consolidated Net Income's 5-year high stood at -$3.0 million during Q3 2025, with a 5-year trough of -$76.3 million in Q1 2022.
- Over the past 5 years, Standard Biotools' median Consolidated Net Income value was -$19.9 million (recorded in 2023), while the average stood at -$26.4 million.
- Per our database at Business Quant, Standard Biotools' Consolidated Net Income crashed by 30582.16% in 2022 and then soared by 7786.58% in 2023.
- Standard Biotools' Consolidated Net Income (Quarter) stood at -$9.4 million in 2021, then tumbled by 121.07% to -$20.8 million in 2022, then rose by 4.56% to -$19.9 million in 2023, then crashed by 277.45% to -$75.1 million in 2024, then skyrocketed by 96.0% to -$3.0 million in 2025.
- Its Consolidated Net Income was -$3.0 million in Q3 2025, compared to -$15.8 million in Q2 2025 and -$26.0 million in Q1 2025.